trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - tüdőbetegség, krónikus obstruktív - gyógyszerek obstruktív légúti betegségek, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
calquence
astrazeneca ab - acalabrutinib - leukémia, limfocitikus, krónikus, b-sejt - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
lumoxiti
astrazeneca ab - moxetumomab pasudotox - leukémia, szőrös sejt - daganatellenes szerek - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).
penthrox 99,9%, 3 ml folyadék inhalációs gőz képzéséhez
medical developments ned b.v. - methoxyflurane -
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - a vakcinák - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. használja ezt a vakcinát a hivatalos ajánlásoknak megfelelően.
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - daganatellenes szerek - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
strangvac
intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - a lófélék immunológiai vizsgálata - lovak - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunszuppresszánsok - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, szisztémás - immunszuppresszánsok - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.